Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential

Myka L. Estes, Julie A. Mund, Laura E. Mead, Daniel N. Prater, Shanbao Cai, Haiyan Wang, Karen Pollok, Michael Murphy, Caroline S T An, Edward Srour, David Ingram, Jamie Case

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Defining whether human circulating proangiogenic cells represent a subset of the hematopoietic system and express CD45 or are hematopoietic derivatives that do not express CD45 (and are called endothelial progenitor cells) remains controversial. We have previously developed a polychromatic flow cytometry (PFC) protocol to isolate subsets of hematopoietic cells and we now identify the circulating pool of CD34+CD45dim cells representing functional circulating hematopoietic stem and progenitor cells (CHSPCs) that can be separated on the basis of AC133 expression and report that the AC133 + subset of the CHSPCs enhances the growth of tumor blood vessels in vivo in immunodeficient mice. In addition, the ratio of AC1331 proangiogenic CHSPCs to AC133- nonangiogenic CHSPCs unambiguously correlates with the severity of the clinical state of patients with peripheral arterial disease. In sum, a PFC protocol validated via in vitro and in vivo analyses, can be used to interrogate the roles of human hematopoietic elements in the growth and maintenance of the vasculature.

Original languageEnglish
Pages (from-to)831-839
Number of pages9
JournalCytometry Part A
Volume77
Issue number9
DOIs
StatePublished - Sep 2010

Fingerprint

Hematopoietic Stem Cells
Flow Cytometry
Vascular Tissue Neoplasms
Hematopoietic System
Peripheral Arterial Disease
Growth
Maintenance

Keywords

  • Angiogenesis
  • Circulating progenitor cells
  • Endothelial progenitor cells
  • Peripheral arterial disease
  • Polychromatic flow cytometry

ASJC Scopus subject areas

  • Cell Biology
  • Histology
  • Pathology and Forensic Medicine

Cite this

Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. / Estes, Myka L.; Mund, Julie A.; Mead, Laura E.; Prater, Daniel N.; Cai, Shanbao; Wang, Haiyan; Pollok, Karen; Murphy, Michael; An, Caroline S T; Srour, Edward; Ingram, David; Case, Jamie.

In: Cytometry Part A, Vol. 77, No. 9, 09.2010, p. 831-839.

Research output: Contribution to journalArticle

Estes, Myka L. ; Mund, Julie A. ; Mead, Laura E. ; Prater, Daniel N. ; Cai, Shanbao ; Wang, Haiyan ; Pollok, Karen ; Murphy, Michael ; An, Caroline S T ; Srour, Edward ; Ingram, David ; Case, Jamie. / Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. In: Cytometry Part A. 2010 ; Vol. 77, No. 9. pp. 831-839.
@article{4452acd5d28c4215a27a9008b85d1ba5,
title = "Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential",
abstract = "Defining whether human circulating proangiogenic cells represent a subset of the hematopoietic system and express CD45 or are hematopoietic derivatives that do not express CD45 (and are called endothelial progenitor cells) remains controversial. We have previously developed a polychromatic flow cytometry (PFC) protocol to isolate subsets of hematopoietic cells and we now identify the circulating pool of CD34+CD45dim cells representing functional circulating hematopoietic stem and progenitor cells (CHSPCs) that can be separated on the basis of AC133 expression and report that the AC133 + subset of the CHSPCs enhances the growth of tumor blood vessels in vivo in immunodeficient mice. In addition, the ratio of AC1331 proangiogenic CHSPCs to AC133- nonangiogenic CHSPCs unambiguously correlates with the severity of the clinical state of patients with peripheral arterial disease. In sum, a PFC protocol validated via in vitro and in vivo analyses, can be used to interrogate the roles of human hematopoietic elements in the growth and maintenance of the vasculature.",
keywords = "Angiogenesis, Circulating progenitor cells, Endothelial progenitor cells, Peripheral arterial disease, Polychromatic flow cytometry",
author = "Estes, {Myka L.} and Mund, {Julie A.} and Mead, {Laura E.} and Prater, {Daniel N.} and Shanbao Cai and Haiyan Wang and Karen Pollok and Michael Murphy and An, {Caroline S T} and Edward Srour and David Ingram and Jamie Case",
year = "2010",
month = "9",
doi = "10.1002/cyto.a.20921",
language = "English",
volume = "77",
pages = "831--839",
journal = "Cytometry. Part A : the journal of the International Society for Analytical Cytology",
issn = "1552-4922",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential

AU - Estes, Myka L.

AU - Mund, Julie A.

AU - Mead, Laura E.

AU - Prater, Daniel N.

AU - Cai, Shanbao

AU - Wang, Haiyan

AU - Pollok, Karen

AU - Murphy, Michael

AU - An, Caroline S T

AU - Srour, Edward

AU - Ingram, David

AU - Case, Jamie

PY - 2010/9

Y1 - 2010/9

N2 - Defining whether human circulating proangiogenic cells represent a subset of the hematopoietic system and express CD45 or are hematopoietic derivatives that do not express CD45 (and are called endothelial progenitor cells) remains controversial. We have previously developed a polychromatic flow cytometry (PFC) protocol to isolate subsets of hematopoietic cells and we now identify the circulating pool of CD34+CD45dim cells representing functional circulating hematopoietic stem and progenitor cells (CHSPCs) that can be separated on the basis of AC133 expression and report that the AC133 + subset of the CHSPCs enhances the growth of tumor blood vessels in vivo in immunodeficient mice. In addition, the ratio of AC1331 proangiogenic CHSPCs to AC133- nonangiogenic CHSPCs unambiguously correlates with the severity of the clinical state of patients with peripheral arterial disease. In sum, a PFC protocol validated via in vitro and in vivo analyses, can be used to interrogate the roles of human hematopoietic elements in the growth and maintenance of the vasculature.

AB - Defining whether human circulating proangiogenic cells represent a subset of the hematopoietic system and express CD45 or are hematopoietic derivatives that do not express CD45 (and are called endothelial progenitor cells) remains controversial. We have previously developed a polychromatic flow cytometry (PFC) protocol to isolate subsets of hematopoietic cells and we now identify the circulating pool of CD34+CD45dim cells representing functional circulating hematopoietic stem and progenitor cells (CHSPCs) that can be separated on the basis of AC133 expression and report that the AC133 + subset of the CHSPCs enhances the growth of tumor blood vessels in vivo in immunodeficient mice. In addition, the ratio of AC1331 proangiogenic CHSPCs to AC133- nonangiogenic CHSPCs unambiguously correlates with the severity of the clinical state of patients with peripheral arterial disease. In sum, a PFC protocol validated via in vitro and in vivo analyses, can be used to interrogate the roles of human hematopoietic elements in the growth and maintenance of the vasculature.

KW - Angiogenesis

KW - Circulating progenitor cells

KW - Endothelial progenitor cells

KW - Peripheral arterial disease

KW - Polychromatic flow cytometry

UR - http://www.scopus.com/inward/record.url?scp=77956454237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956454237&partnerID=8YFLogxK

U2 - 10.1002/cyto.a.20921

DO - 10.1002/cyto.a.20921

M3 - Article

VL - 77

SP - 831

EP - 839

JO - Cytometry. Part A : the journal of the International Society for Analytical Cytology

JF - Cytometry. Part A : the journal of the International Society for Analytical Cytology

SN - 1552-4922

IS - 9

ER -